Predictive Value of Annenxin A1 for Disease Severity and Prognosis in Patients with Community-Acquired Pneumonia

This prospective, single-center study evaluated the clinical utility of annenxin (Anx)A1 level as a biomarker for determining the severity of illness and predicting the risk of death in hospitalized patients with community-acquired pneumonia (CAP). A total of 105 patients (53 with severe [S]CAP, 52...

Descripción completa

Detalles Bibliográficos
Autores principales: Gu, Minghao, Han, Xiudi, Liu, Xuedong, Sui, Fengxiang, Zhang, Quansan, Pan, Shengqi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9914428/
https://www.ncbi.nlm.nih.gov/pubmed/36766501
http://dx.doi.org/10.3390/diagnostics13030396

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9914428/
https://www.ncbi.nlm.nih.gov/pubmed/36766501
http://dx.doi.org/10.3390/diagnostics13030396

Ejemplares similares